drug

SLS009

1 story · latest Aug 11, 2026

Status: Investigational
Code: GFH009
Trials: 1 registered trial in coverage

Relationships

Developed by Sellas Life Sciences Group

Timeline

Sellas reports Q2 2026 results, nears key REGAL trial milestone

Aug 11Quarterly updateSellas Life Sciences Group SLS009

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.